Catherine C. Turkel - Sep 2, 2022 Form 3 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Catherine C. Turkel/
Stock symbol
LEXX
Transactions as of
Sep 2, 2022
Transactions value $
$0
Form type
3
Date filed
9/6/2022, 12:48 PM
Next filing
Oct 13, 2022

No securities are beneficially owned.